Andrea Facciabene, PhD, discusses investigating the use of bridging radiation therapy prior to CAR T-cell therapy in mice models.
Andrea Facciabene, PhD
Advertisement
Articles by Andrea Facciabene, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to Pelareorep Plus Bevacizumab/FOLFIRI in Second-Line KRAS-Mutant mCRC
2
On World Cancer Day, Northwell Highlights a Blueprint for Consistent, System-Wide Cancer Care
3
FDA Grants Priority Review to Frontline Dato-DXd for Metastatic TNBC Ineligible for Immunotherapy
4
Leveraging AI for Optimal Clinical Trial Design in Oncology
5